Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.
Clinical trial NCT01956903 · COMPLETED
Trial details
- NCT number
- NCT01956903
- Sponsor
- Grupo Espanol de trasplantes hematopoyeticos y terapia celular
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2013-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.